恭喜王梦婷博士的工作“HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment”发表在Frontiers in Bioengineering and Biotechnology杂志上，刘雅昕医师为共同第一作者，杨延莲研究员、李惠平教授、朱凌项目研究员、李平高级工程师为共同通讯作者。
https://www.frontiersin.org/articles/10.3389/fbioe.2022.1015295/full
